Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01545167 · ClinicalTrials.gov registry record

The North American Pancreatitis Study

A clinical trial of Pancreatitis, sponsored by University of Pittsburgh.

Completed
Registry status
2,980
Enrollment target
1
Study location

NCT01545167 is a study of Pancreatitis that has completed, run by University of Pittsburgh. The registered enrollment target is 2,980 participants, above the 447-participant average among 17 other Pancreatitis trials with a reported enrollment target (567% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01545167, a study of Pancreatitis, has completed, sponsored by University of Pittsburgh.

COMPLETED
Registry status
2,980 participants
Enrollment target
1
Study location

Study Summary

This study will investigate several genes and other factors measured in the blood that may cause recurrent acute pancreatitis and chronic pancreatitis. No treatment is offered as part of this study. Subjects have one single visit to provide a blood sample for genetic testing and to answer a questionnaire. Subjects are not given results of genetic testing. The study is currently enrolling African American subjects and controls only.

Conditions Studied

Interventions

  • GENETIC blood sampling

Study Locations (1)

Pennsylvania

  • University of Pittsburgh - Pittsburgh

Trial Details

FieldValue
Enrollment Target 2,980 participants
Start Date 2008-09
Est. Completion 2014-06

Sponsor

University of Pittsburgh

1,238 total trials

What the Registry Record Tells You About NCT01545167

The ClinicalTrials.gov registry entry for NCT01545167 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 2,980 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 447-participant average among 17 other Pancreatitis trials with a reported enrollment target (567% higher). The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pancreatitis appearing as the primary indexed condition, and to 1 intervention - of which blood sampling is the first listed.

NCT01545167 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT01545167 about?

NCT01545167 is a clinical study titled "The North American Pancreatitis Study". This study will investigate several genes and other factors measured in the blood that may cause recurrent acute pancreatitis and chronic pancreatitis. No treatment is offered as part of this study. Subjects have one single visit to provide a blood sample for genetic testing and to answer a question...

What is the current status of trial NCT01545167?

This trial is currently completed. The enrollment target is 2,980 participants. The study started on 2008-09. Estimated completion is 2014-06.

What conditions does trial NCT01545167 study?

This clinical trial studies the following conditions: Pancreatitis.

What interventions are being tested in trial NCT01545167?

The interventions under investigation include: blood sampling (GENETIC).

Who is sponsoring clinical trial NCT01545167?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01545167 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pancreatitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.